Literature DB >> 23696570

Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone.

Ji Young Kim1, Kai Xue, Mingju Cao, Qi Wang, Jia-Yin Liu, Arthur Leader, Jae Yong Han, Benjamin K Tsang.   

Abstract

In the present study, we have investigated the cellular mechanisms of androgen-induced antral follicular growth arrest and the possible involvement of chemerin and its receptor chemokine-like receptor 1 (CMKLR1) in this process, using a chronically androgenized rat model. We hypothesize that hyperandrogenism induces antral follicle growth arrest via the action of chemerin and ovarian structural changes, resulting from granulosa cell and oocyte apoptosis and theca cell survival. Dihydrotestosterone (DHT) treatment resulted in increased expression of chemerin and CMKLR1 in antral follicles, absence of corpus luteum, and increased atypical follicles. Addition of chemerin to follicle cultures induced granulosa cell apoptosis and suppressed basal, FSH- and growth differentiation factor-9-stimulated follicular growth. DHT down-regulated aromatase expression and increased active caspase-3 content and DNA fragmentation in granulosa cells in vivo. These changes were accompanied by higher phosphatase and tensin homolog and lower phospho-Akt (Ser473) content in antral follicles and higher calpain expression and down-regulation of cytoskeletal proteins in atypical follicles, which were constituted predominantly of theca cells. DHT also activated granulosa cell caspase-3, decreased X-linked inhibitor of apoptosis protein, poly(ADP-ribose) polymerase, and phospho-Akt contents and induced apoptosis in vitro, responses readily attenuated by forced X-linked inhibitor of apoptosis protein expression. These findings are consistent with our hypothesis that antral follicular growth arrest in DHT-treated rats results from increased chemerin expression and action, as well as changes in follicular cell fate and structure, which are a consequence of dysregulated interactions of pro-survival and pro-apoptotic modulators in a cell-specific manner. Our observations suggest that this chronically androgenized rat model may be useful for studies on the long-term effects of androgens on folliculogenesis and may have implications for the female reproductive disorders associated with hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23696570     DOI: 10.1210/en.2013-1001

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.

Authors:  Patricia D A Lima; Anne-Laure Nivet; Qi Wang; Yi-An Chen; Arthur Leader; Annie Cheung; Chii-Ruey Tzeng; Benjamin K Tsang
Journal:  Biol Reprod       Date:  2018-10-01       Impact factor: 4.285

Review 2.  Synthesis, Regulatory Factors, and Signaling Pathways of Estrogen in the Ovary.

Authors:  Chuyu Xiao; Jing Wang; Chunping Zhang
Journal:  Reprod Sci       Date:  2022-04-06       Impact factor: 3.060

3.  The phosphorylation and dephosphorylation switch of VCP/p97 regulates the architecture of centrosome and spindle.

Authors:  Kaiyuan Zhu; Yang Cai; Xiaotong Si; Zuodong Ye; Yuanzhu Gao; Chuang Liu; Rui Wang; Zhibin Ma; Huazhang Zhu; Liang Zhang; Shengjin Li; Hongmin Zhang; Jianbo Yue
Journal:  Cell Death Differ       Date:  2022-04-16       Impact factor: 12.067

4.  Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women.

Authors:  Lingxia Ha; Yuhua Shi; Junli Zhao; Tao Li; Zi-Jiang Chen
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

5.  Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation.

Authors:  Nahid Kabiri; Mohammad Reza Tabandeh; Seyed Reza Fatemi Tabatabaie
Journal:  Daru       Date:  2014-04-24       Impact factor: 3.117

6.  CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.

Authors:  Mi Tang; Chen Huang; Yu-Fei Wang; Pei-Gen Ren; Li Chen; Tian-Xia Xiao; Bao-Bei Wang; Yan-Fei Pan; Benjamin K Tsang; Brian A Zabel; Bao-Hua Ma; Hui-Ying Zhao; Jian V Zhang
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 7.  Adipokines and the female reproductive tract.

Authors:  Maxime Reverchon; Christelle Ramé; Michael Bertoldo; Joëlle Dupont
Journal:  Int J Endocrinol       Date:  2014-02-18       Impact factor: 3.257

8.  Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest.

Authors:  Hideaki Tsuyoshi; Vincent Kam Wai Wong; Yu Han; Makoto Orisaka; Yoshio Yoshida; Benjamin K Tsang
Journal:  Oncotarget       Date:  2017-09-16

9.  Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome.

Authors:  Jung Jin Lim; Patricia D A Lima; Reza Salehi; Dong Ryul Lee; Benjamin K Tsang
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

10.  The role of fructose‑1,6‑bisphosphatase 1 in abnormal development of ovarian follicles caused by high testosterone concentration.

Authors:  Tao Liu; Han Zhao; Jianfeng Wang; Xin Shu; Yuan Gao; Xiaoli Mu; Fei Gao; Hongbin Liu
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.